Our Unique Experience with Low-Dose Alemtuzumab as an Induction Agent for Renal Transplantation: A Case Series
The use of an induction agent in renal transplant is based on the center or physician’s protocol. Alemtuzumab was used as an induction agent in 1998 for the first time and has been used since then as an induction agent off-label. There has been no consensus on the dosage of alemtuzumab. We describe...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Series: | Indian Journal of Transplantation |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ijot.ijot_41_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|